CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 23, 2019

Primary Completion Date

May 6, 2019

Study Completion Date

May 6, 2019

Conditions
Pancreatic Neuroendocrine Tumor
Interventions
OTHER

CT radiomic feature evaluation

"Radiomic features will be calculated and extracted from all contrast and non-contrast CT-scans. First order features will be evaluated and high order features will be grouped in parent matrices. Parent matrices of second and third order will be chosen and evaluated.~In the second part, based on the results of inter-correlation of the operator analysis, the most significant radiomic features will be chosen. Morphological and histopathological features will be evaluated will be.~Histopathology will be performed on a biopsy specimen; percentage of Ki67 and grading will be evaluated."

Trial Locations (2)

20132

Deaprtment of Radiology, IRCCS Ospadale San Raffaele, Milan

20153

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
lead

Francesco De Cobelli

OTHER

NCT03967951 - CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms | Biotech Hunter | Biotech Hunter